Strides Pharma Science Limited has informed the Exchange regarding a press release dated November 21, 2023, titled "Strides receives USFDA approval for Levetiracetam Oral Solution".
Strides Pharma Science Limited has informed the Exchange regarding a press release dated November 21, 2023, titled "Strides receives USFDA approval for Levetiracetam Oral Solution".